AOD-9604: A Complete Guide to the Fat-Loss Peptide in 2026

AOD-9604 is a lab-made piece of human growth hormone, the tail end tied to burning fat. Fans call it a fat-loss peptide. Here's the key point: across six early trials and about 900 people, it did not beat placebo for weight loss, and US pharmacies cannot legally compound it in 2026. This guide covers what AOD-9604 is, what the studies found, its FDA status, and safer prescribed options for weight loss.

What is AOD-9604?

AOD-9604 is a small piece of human growth hormone (hGH), copied in a lab. It's the tail end of the hormone, the part tied to fat metabolism. Researchers built it to try to burn fat without the growth or blood-sugar effects of full hGH. It is not offered by pru, and as of 2026 it cannot be legally compounded by US pharmacies.

The name is short for "Anti-Obesity Drug 9604." You'll also see it called HGH Fragment 176-191, after the amino acids it copies. It was developed in the 1990s at Monash University in Australia and given as a small injection under the skin in research settings.

How is AOD-9604 supposed to work?

AOD-9604 aims to act on fat cells the way the tail of hGH does. In lab and animal studies it nudged fat cells to release stored fat and slowed the making of new fat. It did this without raising IGF-1 or affecting blood sugar in those studies.

• Signals fat cells to break down stored fat (lipolysis).
• Aims to reduce the storage of new fat (lipogenesis).
• In studies, did not raise IGF-1 or change blood sugar the way full hGH can.
• Delivered as a small under-the-skin injection in research protocols.

This is a different idea from GLP-1 medicines. A GLP-1 like compounded semaglutide works on appetite and digestion, so you eat less. AOD-9604 was meant to act directly on fat cells. That distinction matters when you read the research below.

Is AOD-9604 the same as HGH fragment 176-191?

Almost, but not exactly. HGH fragment 176-191 is the raw stretch of amino acids from the hormone. AOD-9604 is that same fragment with one extra piece added (a tyrosine) to make it more stable for study. In everyday talk the two names get used for the same thing, but AOD-9604 is the version that went through formal trials.

Does AOD-9604 work for fat loss?

The short answer: it worked in mice, not in people. In obese mice, AOD-9604 cut body weight and body fat over about two weeks. In humans, the story changed. Early safety trials went well, but the largest weight-loss study did not show meaningful weight loss over placebo. The developer dropped it as a drug candidate in 2007.

So the fat-loss promise you see online rests mostly on animal data and early lab work rather than strong human results.

The more decisive point is regulatory: AOD-9604 is still pending FDA review and has no cleared, regulated compounding pathway yet, so there is no legitimate prescribed version to weigh in the first place. pru only offers peptides a licensed physician can prescribe and an FDA-registered 503A pharmacy can compound, and until AOD-9604 reaches that kind of overseen pathway the sound move is to wait for it rather than order a research-only vial with no prescriber or pharmacy behind it.

AOD-9604 vs GLP-1 medicines for weight loss

Here's the contrast in plain terms: AOD-9604 aimed to melt fat but did not prove it in people, while GLP-1 medicines curb appetite and have strong human trial data behind them. GLP-1s are also available today through a physician and a licensed pharmacy. AOD-9604 is not.

If your goal is weight loss with real oversight, a GLP-1 is the better-studied path. See how the two GLP-1s compare in semaglutide vs tirzepatide, or read about the typical GLP-1 weight-loss timeline.

Is AOD-9604 legal or FDA approved in 2026?

AOD-9604 is not FDA approved for any medical use, and in 2026 US pharmacies cannot legally compound it. Any weight-loss claim tied to a prescription version is off the table, because no legal prescription version exists.

• It has never passed a Phase III trial, and no company has an approved drug.
• It once carried a self-affirmed GRAS label for supplement use, which is not the same as approval for treating anything.
• The FDA placed it on Category 2 of the interim 503A bulks list, flagging safety concerns.
• At the December 4, 2024 Pharmacy Compounding Advisory Committee meeting, the panel voted against adding AOD-9604 to the 503A list, citing immunogenicity risk and thin safety data.

Where AOD-9604 is sold, and why to be careful

Since no pharmacy can compound it, the AOD-9604 you find online is research-grade material, often labeled "not for human use." That means no prescriber, no licensed pharmacy, and no quality guarantee. This is the one place in this guide where real caution belongs.

• Vials sold as "research only" skip the checks a licensed pharmacy provides.
• Purity, dose, and sterility are not verified by any regulator.
• There's no physician reviewing whether it fits your health.
• Immunogenicity, an immune reaction to the peptide, was a specific FDA concern.

If a site promises easy AOD-9604 for weight loss, treat that as a red flag, not a shortcut.

What to consider instead of AOD-9604

If you want help with weight and metabolic health, the better-studied path is a prescribed GLP-1 with real oversight. It pairs a proven medicine with a physician and a licensed pharmacy, which is exactly what research-grade AOD-9604 lacks. Looking into this at all means you are already being proactive about your metabolic health, and that instinct is worth trusting; the payoff comes from pairing it with real oversight rather than a grey-market shortcut.

Small habits still do the heavy lifting: steady protein, strength training, and sleep. A GLP-1 can support the effort by easing appetite. For a fuller map of options, see the best peptides for weight loss.

How pru handles AOD-9604 and weight loss

pru does not offer AOD-9604. Because it isn't on the 503A list, there is no compliant, compounded version to offer, and we won't point you to a grey-market vial. We cover it here so you can make an informed call.

What pru does offer is compounded semaglutide and tirzepatide for weight loss. These are well-studied GLP-1 medicines made by an FDA-regulated 503A pharmacy. They are pharmacy-grade, prescribed after a physician reviews your health. You select the option that fits your goals, and the physician confirms whether it's clinically appropriate.

pru runs on a membership of about $50 a month, and peptides are billed at cost, itemized, with no member markup. A higher dose costs a bit more because it's more medicine, never because of a markup. pru exists to make the proactive, informed choice the accessible one, so the smart path is also the easy one. When you're ready to take the next step, see the fat loss and metabolism catalog or membership pricing.

Related reading

Keep exploring peptides and weight-loss options:

• Tesamorelin vs AOD-9604
• AOD-9604 dosage guide
• Tesamorelin guide
• MOTS-c guide
• Best peptides for weight loss
• Semaglutide vs tirzepatide
• Shop fat loss and metabolism

Common questions